A novel glycine site-specific N-methyl- d-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia

Intrastriatal administration of ammonium ions (“ammonia”) via a microdialysis probe overactivates N-methyl- d-aspartate (NMDA) receptors, which results in cGMP accumulation in the microdialysates. Co-administration of a potent glycine site-specific NMDA receptor antagonist CGP 78608 ([(1 S)-1-[[(7-b...

Full description

Saved in:
Bibliographic Details
Published inBrain research Vol. 1015; no. 1; pp. 186 - 188
Main Authors Hilgier, Wojciech, Oja, Simo S, Saransaari, Pirjo, Albrecht, Jan
Format Journal Article
LanguageEnglish
Published London Elsevier B.V 23.07.2004
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Intrastriatal administration of ammonium ions (“ammonia”) via a microdialysis probe overactivates N-methyl- d-aspartate (NMDA) receptors, which results in cGMP accumulation in the microdialysates. Co-administration of a potent glycine site-specific NMDA receptor antagonist CGP 78608 ([(1 S)-1-[[(7-bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonate) significantly reduced (at 20 nM) or abolished (at 100 nM) ammonia-dependent cGMP synthesis. Since NMDA receptor activation is an important causative factor in ammonia neurotoxicity, the present results suggest the glycine site of the receptor to be a potential valuable target for protective intervention.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0006-8993
1872-6240
DOI:10.1016/j.brainres.2004.05.014